ARCHIVES

Sorafenib Targets AML Driven By Mutant FLT3 Gene

This article is from The Cancer Letter archive.

Vol. 31 No. 2 | February 29, 2008

Download PDF Visit The Full Archive

Related Articles

ACS-Roosevelt Awards Go to 19 New Fellows

July 30, 1976

In Brief: Conferees Ok NCI Appropriations At $691.7 Million; Final Amount Available Won’t Be Set Until Spring

November 29, 1974

NIH To Site Visit Animal Facilities

March 18, 1983

Acupuncture Eases Radiation-Induced Dry Mouth In Patients

April 24, 2009

Susan Weiner Named to HHS Panel

January 17, 2003

Zevalin Regimen Better Than Rituximab Alone For NHL

June 29, 2001